Palmitoylation licenses RIPK1 kinase activity and cytotoxicity in the TNF pathway
Molecular Cell · 2024-11 · 84 (22) · 4419-4435.e10
DOI: 10.1016/j.molcel.2024.10.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2024-11. Verfasst von Na Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201210, Ch…. Hauptthemen laut MEDLINE: Lipoylation, Receptor-Interacting Protein Serine-Threonine Kinases, Ubiquitination, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: National Science Fund for Distinguished Young Scholars, National Natural Science Foundation of China, Shanghai Science and Technology Development Foundation.
Abstract (Originalsprache)
Tumor necrosis factor (TNF)-induced receptor-interacting serine/threonine protein kinase 1 (RIPK1)-mediated cell death, including apoptosis and necroptosis, is increasingly recognized as a major driver of inflammatory diseases. Cell death checkpoints normally suppress RIPK1 kinase to safeguard the organism from its detrimental consequences. However, the mechanisms licensing RIPK1 kinase activity when a protective checkpoint is disabled remain unclear. Here, we identified S-palmitoylation as a licensing modification for RIPK1 kinase. TNF induces RIPK1 palmitoylation, mediated by DHHC5 and dependent on K63-linked ubiquitination of RIPK1, which enhances RIPK1 kinase activity by promoting the homo-interaction of its kinase domain and promotes cell death upon cell death checkpoint blockade. Furthermore, DHHC5 is amplified by fatty acid in the livers of mice with metabolic dysfunction-associated steatohepatitis, contributing to increased RIPK1 cytotoxicity observed in this condition. Our findings reveal that ubiquitination-dependent palmitoylation licenses RIPK1 kinase activity to induce downstream cell death signaling and suggest RIPK1 palmitoylation as a feasible target for inflammatory diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201210, China; University of Chinese Academy of Sciences, Beijing 101408, China.
- Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201210, China.
- Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai 201210, China; Shanghai Key Laborshiatory of Aging Studies, Shanghai 201210, Chi…
- Center for Liver Transplantation, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei, China; Key Laboratory of Organ Transplantation, Ministry of Education, NHC Ke…
Förderung
- National Science Fund for Distinguished Young Scholars
- National Natural Science Foundation of China
- Shanghai Science and Technology Development Foundation
- Chinese Academy of Sciences
- Fudan University
Zitieren
APA
Zhang, N., Liu, J., Guo, R., Yan, L., Yang, Y., Shi, C., Zhang, M., Shan, B., Li, W., Gu, J., & Xu, D. (2024). Palmitoylation licenses RIPK1 kinase activity and cytotoxicity in the TNF pathway. Molecular Cell, 84(22), 4419-4435.e10. https://doi.org/10.1016/j.molcel.2024.10.002
Vancouver
Zhang N, Liu J, Guo R, Yan L, Yang Y, Shi C, et al. Palmitoylation licenses RIPK1 kinase activity and cytotoxicity in the TNF pathway. Molecular Cell. 2024;84(22):4419-4435.e10. doi:10.1016/j.molcel.2024.10.002
BibTeX
@article{Zhang2024,
author = {Zhang, Na and Liu, Jianping and Guo, Rui and Yan, Lingjie and Yang, Yuanxin and Shi, Chen and Zhang, Mengmeng and Shan, Bing and Li, Wanjin and Gu, Jinyang and Xu, Daichao},
title = {Palmitoylation licenses RIPK1 kinase activity and cytotoxicity in the TNF pathway},
journal = {Molecular Cell},
year = {2024},
volume = {84},
number = {22},
pages = {4419--4435.e10},
doi = {10.1016/j.molcel.2024.10.002}
}
EUVIMED